About EnzyQuest

Innovating Molecular Biology Through AI-Driven Enzyme Discovery

Who we are

EnzyQuest is a Crete-based biotechnology company

High-performance molecular biology enzymes, diagnostic kits, and custom solutions for research and industry.
img 2
AI-Driven Enzyme Engineering

Accelerating enzyme development through machine-learning assisted modeling.

ISO-Certified Manufacturing

Consistent quality, validated protocols, and robust QC processes.

Custom Molecular Solutions

Tailored reagents, OEM formulations, and workflow-specific optimization.

Orders from Greece & Cyprus

Please contact our exclusive distributor, Lab Supplies Scientific

ENZYQUEST

EnzyQuest develops, manufactures, and distributes advanced molecular biology reagents and diagnostic kits. With in-house R&D and ISO-certified processes, the company focuses on delivering high-performance enzymes, qPCR tools, and customized molecular solutions for research, healthcare, and industrial partners.

Our scientific team combines computational design, AI-driven modeling, and classical wet-lab experimentation to develop enzyme variants with improved specificity, tolerance, and robustness across challenging substrates.

Our portfolio supports applications across PCR, qPCR, RT, RNA workflows, high-fidelity amplification, and wastewater molecular diagnostics.

EnzyQuest operates from Heraklion, Crete, collaborating with academic, commercial, and diagnostic partners across Greece and Europe.

Milestones

Enzyquest by the years…

November 2019

Secured venture capital investment from Uni.Fund

January 2020

Exclusive commercialization agreement with FORTH/IMBB

August 2020

Launched Greece's first wastewater SARS-CoV-2 surveillance station (Salonica)

November 2020

Awarded EU Horizon 2020 funding for SARS-CoV-2 detection kit (IRIS-COV)

December 2020

Launched Greece's only RT-qPCR COVID-19 detection kit using proprietary reagents

March 2021

ISO 13485:2016 certified (first in Greece for molecular reagents)

May 2021

EOF (National Organisation For Medicines) approval as licensed IVD manufacturer (first in Greece)

June 2021

Initiated OEM manufacturing for COVID-19 detection kits

November 2021

Became member of Hellenic Biocluster (H-Bio)

March 2022

Participated in BIOCATDIESEL research project

August 2022

AI enzyme design tools recognized as EU Innovation Radar semi-finalist

February 2023

Expanded PCR/qPCR product line

December 2023

Developed SARS-CoV-2 wastewater detection tool for national surveillance network

July 2024

Secured Horizon Europe funding to establish DxHub Center of Excellence

January 2025

Launched Influenza A/B wastewater detection assay for national network

Our Vision

To transform enzyme discovery and molecular diagnostics through smart, efficient, and sustainable biotechnology.

Our Mission

To develop high-quality enzymes and molecular tools that empower researchers, laboratories, and biotech organizations worldwide.

Our Motto

Smarter Enzymes. Stronger Science.

Company Legal Details